Involvement of Urokinase-Type Plasminogen Activator System in Cancer: An Overview
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Involvement of Urokinase-Type Plasminogen Activator System in Cancer: An Overview
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume 34, Issue 5, Pages 918-956
Publisher
Wiley
Online
2014-02-19
DOI
10.1002/med.21308
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- uPA and PAI-1-Related Signaling Pathways Differ between Primary Breast Cancers and Lymph Node Metastases
- (2014) Katharina Malinowsky et al. Translational Oncology
- Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer
- (2013) V Heinemann et al. BRITISH JOURNAL OF CANCER
- Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
- (2013) N. Harbeck et al. EUROPEAN JOURNAL OF CANCER
- EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression
- (2012) Géraldine Lescaille et al. BMC CANCER
- VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution
- (2012) Revu Ann Alexander et al. CARDIOVASCULAR RESEARCH
- A potency of plasminogen activation system in long-term prognosis of endometrial cancer: a pilot study
- (2012) Samulak Dariusz et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Regulation of EMT by TGFβ in cancer
- (2012) Carl-Henrik Heldin et al. FEBS LETTERS
- A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2012) Michael A. Gold et al. GYNECOLOGIC ONCOLOGY
- Crystal Structure of the Urokinase Receptor in a Ligand-Free Form
- (2012) Xiang Xu et al. JOURNAL OF MOLECULAR BIOLOGY
- The urokinase receptor (CD87) represents a central mediator of growth factor-induced endothelial cell migration
- (2012) Marina Poettler et al. THROMBOSIS AND HAEMOSTASIS
- HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase-Type Plasminogen Activator Receptor
- (2012) Ahmed H. Mekkawy et al. Journal of Oncology
- Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group
- (2011) Claudio Sorio et al. BMC CANCER
- Cytotoxicity of VEGF121/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2
- (2011) Khalid A Mohamedali et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Increased Plasma Soluble uPAR Level Is a Risk Marker of Respiratory Cancer in Initially Cancer-Free Individuals
- (2011) A. Langkilde et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1
- (2011) Manfred Schmitt et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- An immunohistochemical analysis-based decision tree model for estimating the risk of lymphatic metastasis in pN0 squamous cell carcinomas of the lung
- (2011) Yu Liu et al. HISTOPATHOLOGY
- Urokinase plasminogen activator receptor on invasive cancer cells: A prognostic factor in distal gastric adenocarcinoma
- (2011) Warner Alpízar-Alpízar et al. INTERNATIONAL JOURNAL OF CANCER
- Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistry
- (2011) Ole Didrik Laerum et al. INTERNATIONAL JOURNAL OF CANCER
- Mimicry of the Regulatory Role of Urokinase in Lamellipodia Formation by Introduction of a Non-native Interdomain Disulfide Bond in Its Receptor
- (2011) Henrik Gårdsvoll et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Grading of Gliomas: The Road From Eminence to Evidence
- (2011) Johan M. Kros JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Urokinase receptor forms in serum from non-small cell lung cancer patients: Relation to prognosis
- (2011) Charlotte Elberling Almasi et al. LUNG CANCER
- Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients
- (2011) J. HALAMKOVA et al. NEOPLASMA
- Cytokine networks in glioma
- (2011) Kenichiro Iwami et al. NEUROSURGICAL REVIEW
- Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer
- (2010) J. Dorn et al. ANNALS OF ONCOLOGY
- Novel protein interactors of urokinase-type plasminogen activator receptor
- (2010) Ahmed H. Mekkawy et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Urokinase and Tissue Plasminogen Activators and Their PAI-1 Inhibitor in Tumors of Patients with Oral Mucosal Cancer: Relationship with the Main Clinical Morphological Factors
- (2010) E. S. Gershtein et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- High Expression of the Urokinase Plasminogen Activator and Its Cognate Receptor Associates with Advanced Stages and Reduced Disease-Free Interval in Papillary Thyroid Carcinoma
- (2010) Salvatore Ulisse et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening
- (2010) A. Kjellman et al. JOURNAL OF INTERNAL MEDICINE
- uPA/PAI-1 expression and uPA promoter methylation in meningiomas
- (2010) Julia Annabel Kandenwein et al. JOURNAL OF NEURO-ONCOLOGY
- Survey of risk factors contributed to lymphatic metastasis in patients with oral tongue cancer by immunohistochemistry
- (2010) Zhuang Zhang et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- The soluble form of urokinase receptor promotes angiogenesis through its Ser88-Arg-Ser-Arg-Tyr92 chemotactic sequence
- (2010) K. BIFULCO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells
- (2010) Theodore S. Nowicki et al. LARYNGOSCOPE
- Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer
- (2010) Charlotte E. Almasi et al. PROSTATE
- Plasminogen Activators in Ischemic Stroke: Introduction
- (2010) G. J. del Zoppo STROKE
- Amplification of the Urokinase-Type Plasminogen Activator Receptor (uPAR) Gene in Ductal Pancreatic Carcinomas Identifies a Clinically High-Risk Group
- (2009) Ralf Hildenbrand et al. AMERICAN JOURNAL OF PATHOLOGY
- Expression of MMP-2, MMP-9, and Urokinase-Type Plasminogen Activator in Cervical Intraepithelial Neoplasia
- (2009) Jae Hong No et al. Annals of the New York Academy of Sciences
- Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer
- (2009) CHARLOTTE ELBERLING ALMASI et al. APMIS
- Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non-malignant conditions in patients presenting with symptoms related to colorectal cancer
- (2009) A F Lomholt et al. BRITISH JOURNAL OF CANCER
- Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression
- (2009) H Chen et al. BRITISH JOURNAL OF CANCER
- High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer
- (2009) Ó. Vidal et al. BRITISH JOURNAL OF SURGERY
- Analysis of NM23 Protein and Components of Plasminogen Activation System in Tumors of Patients with Stomach Cancer with Consideration for Disease Clinical Picture and Morphology
- (2009) N. E. Kushlinskii et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Urokinase plasminogen activator system as a potential target for cancer therapy
- (2009) Ahmed H Mekkawy et al. Future Oncology
- Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients
- (2009) Li Wang et al. GYNECOLOGIC ONCOLOGY
- Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer
- (2009) Parham Minoo et al. HUMAN PATHOLOGY
- Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies
- (2009) Daniel Buergy et al. INTERNATIONAL JOURNAL OF CANCER
- Urokinase plasminogen activator receptor is expressed in invasive cells in gastric carcinomas from high- and low-risk countries
- (2009) Warner AlpÃzar-AlpÃzar et al. INTERNATIONAL JOURNAL OF CANCER
- Reversibility of Epithelial-Mesenchymal Transition (EMT) Induced in Breast Cancer Cells by Activation of Urokinase Receptor-dependent Cell Signaling
- (2009) Minji Jo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased Urokinase-Type Plasminogen Activator Receptor and Epidermal Growth Factor Receptor in Serum of Patients With Prostate Cancer
- (2009) Giulio Milanese et al. JOURNAL OF UROLOGY
- Prognostic Significance of Growth Factors and the Urokinase-Type Plasminogen Activator System in Pancreatic Ductal Adenocarcinoma
- (2009) Aiqun Xue et al. PANCREAS
- Prognostic Value of Tumor-Related Molecular Expression in Gastric Carcinoma
- (2009) Zhong-Sheng Zhao et al. PATHOLOGY & ONCOLOGY RESEARCH
- Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence
- (2009) Robert S. Svatek et al. PROSTATE
- Differential Prognostic Impact of uPA and PAI-1 in Colon and Rectal Cancer
- (2009) Marcus Langenskiöld et al. TUMOR BIOLOGY
- Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness
- (2008) Adriana Sergio et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues
- (2008) Paul N. Span et al. BJU INTERNATIONAL
- Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer
- (2008) Christian Thomas et al. BJU INTERNATIONAL
- Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein
- (2008) G. W. Prager et al. BLOOD
- Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study
- (2008) Roberta Bacchiocchi et al. BMC CANCER
- Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer
- (2008) László Herszényi et al. BMC CANCER
- Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases
- (2008) Y Kita et al. BRITISH JOURNAL OF CANCER
- Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based Biomarkers
- (2008) S. F. Shariat et al. CLINICAL CANCER RESEARCH
- Cleaved Forms of the Urokinase Plasminogen Activator Receptor in Plasma Have Diagnostic Potential and Predict Postoperative Survival in Patients with Ovarian Cancer
- (2008) E. Henic et al. CLINICAL CANCER RESEARCH
- Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers
- (2008) László Herszényi et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Predictive Value of the Differential Expression of the Urokinase Plasminogen Activation Axis in Radical Prostatectomy Patients
- (2008) Amit Gupta et al. EUROPEAN UROLOGY
- A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer
- (2008) Sharad A. Ghamande et al. GYNECOLOGIC ONCOLOGY
- Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with 1 integrins
- (2008) C.-H. Tang et al. JOURNAL OF CELL SCIENCE
- uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro
- (2008) S. D'Alessio et al. JOURNAL OF CELL SCIENCE
- uPA and PAI-1 in Rectal Cancer—Relationship to Radiotherapy and Clinical Outcome
- (2008) Eva Angenete et al. JOURNAL OF SURGICAL RESEARCH
- Seprase, Dipeptidyl Peptidase IV and Urokinase-Type Plasminogen Activator Expression in Dysplasia and Invasive Squamous Cell Carcinoma of the Esophagus
- (2008) Mariusz Adam Goscinski et al. ONCOLOGY
- Clathrin and LRP-1-Independent Constitutive Endocytosis and Recycling of uPAR
- (2008) Katia Cortese et al. PLoS One
- Expression of urokinase-type plasminogen activator system in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy
- (2008) Masafumi Kumano et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Plasminogen Activation–Induced Pericellular Fibronectin Proteolysis Promotes Fibroblast Apoptosis
- (2007) Jeffrey C. Horowitz et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now